Bioregenx, Inc. financial data

Symbol
BRGX on OTC
Industry
Services-Computer Programming, Data Processing, Etc.
Location
7407 Ziegler Road, Chattanooga, TN
State of incorporation
NV
Fiscal year end
December 31
Former names
FINDIT, INC. (to 1/18/2024), ARTEMIS ENERGY HOLDINGS, INC. (to 12/11/2013)
Latest financial report
10-K/A - Q4 2024 - Apr 16, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.7 % -49.2%
Quick Ratio 4.49 %
Debt-to-equity 37.7 %
Return On Equity -234 % -260%
Return On Assets -170 % +87.5%
Operating Margin -973 % -873%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 957M shares +0.04%
Common Stock, Shares, Outstanding 957M shares +24.2%
Entity Public Float 5.59M USD +31.6%
Common Stock, Value, Issued 957K USD +24.2%
Weighted Average Number of Shares Outstanding, Basic 940M shares +46.8%
Weighted Average Number of Shares Outstanding, Diluted 940M shares +46.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.34M USD -31.4%
Cost of Revenue 682K USD -38%
Research and Development Expense 0 USD -100%
Operating Income (Loss) -22.8M USD -568%
Nonoperating Income (Expense) -522K USD -258%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.75M USD -546%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -23.1M USD -540%
Earnings Per Share, Basic -0.02 USD/shares -100%
Earnings Per Share, Diluted -0.02 USD/shares -100%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58.4K USD -53.4%
Accounts Receivable, after Allowance for Credit Loss, Current 15K USD -85.7%
Inventory, Net 111K USD -48.9%
Other Assets, Current 118K USD -17.2%
Assets, Current 308K USD -52.8%
Property, Plant and Equipment, Net 201K USD +1363%
Intangible Assets, Net (Excluding Goodwill) 17.1M USD
Goodwill 7.11M USD
Other Assets, Noncurrent 0 USD -100%
Assets 509K USD -41.3%
Accounts Payable, Current 427K USD +76.9%
Employee-related Liabilities, Current 48K USD
Accrued Liabilities, Current 453K USD +30.7%
Liabilities, Current 3.63M USD +30.4%
Liabilities 3.89M USD +32.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.03K USD
Retained Earnings (Accumulated Deficit) -35.6M USD -184%
Stockholders' Equity Attributable to Parent -3.38M USD -63.1%
Liabilities and Equity 509K USD -41.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -104K USD +69%
Net Cash Provided by (Used in) Financing Activities 283K USD +71.5%
Net Cash Provided by (Used in) Investing Activities -191K USD
Common Stock, Shares Authorized 1.5B shares 0%
Common Stock, Shares, Issued 957M shares +24.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.2K USD +93.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 58.4K USD -53.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 3.32M USD +128%
Payments to Acquire Property, Plant, and Equipment 189K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.1M USD -544%
Deferred Tax Assets, Operating Loss Carryforwards 1.37M USD +94.3%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 31M USD +220%
Amortization of Intangible Assets 562K USD
Depreciation, Depletion and Amortization 521K USD +937%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 292K USD